Aflibercept 3.6mg/90microlitres solution for injection pre-filled syringes
NHS hospitals in England used £321,575,568 of indicative cost of Aflibercept 3.6mg/90microlitres solution for injection pre-filled syringes in the 12 months to April 2026, about 1.3% of all hospital medicines spend. That is down 31.8% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Aflibercept 3.6mg/90microlitres solution for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Aflibercept 3.6mg/90microlitres solution for injection pre-filled syringes most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Moorfields Eye Hospital Nhs Ft | £19,051,232 |
| South Tees Hosp Nhs Foundation Trust | £11,022,266 |
| York Teaching Hospital Nhs Ft | £9,980,962 |
| King's College Hpl Nhs Foundation Trust | £8,156,774 |
| Shrewsbury & Telford Hospital Nhs Trust | £7,439,176 |
| Derby Teaching Hospitals Nhs Found Trust | £7,393,874 |
| Manchester University Nhs Ft | £7,107,388 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £6,845,574 |
| Oxford University Hospitals Nhs Ft | £6,798,400 |
| Univ Hpl B/Ham Nhs Foundation Trust | £6,540,710 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.